|
1
|
Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study.
|
J Clin Oncol
|
2001
|
1.32
|
|
2
|
Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study.
|
J Clin Oncol
|
2001
|
1.17
|
|
3
|
Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells.
|
Proc Natl Acad Sci U S A
|
1987
|
1.08
|
|
4
|
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).
|
Ann Oncol
|
2007
|
1.08
|
|
5
|
Anaemia in cancer: pathophysiology and treatment.
|
Cancer Treat Rev
|
2000
|
1.05
|
|
6
|
Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
|
Ann Oncol
|
2006
|
0.94
|
|
7
|
Acute pain syndrome at tumour site in neoplastic patients treated with vinorelbine: report of unusual toxicity.
|
Eur J Cancer
|
1994
|
0.91
|
|
8
|
Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy.
|
Oncology
|
1995
|
0.90
|
|
9
|
Single agent paclitaxel in advanced squamous cell head and neck carcinoma.
|
Eur J Cancer
|
1996
|
0.90
|
|
10
|
A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group.
|
Ann Oncol
|
1995
|
0.89
|
|
11
|
A combination of platinum and tamoxifen in advanced ovarian cancer failing platinum-based chemotherapy: results of a Phase II study.
|
Int J Gynecol Cancer
|
2002
|
0.87
|
|
12
|
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.).
|
Ann Oncol
|
1996
|
0.86
|
|
13
|
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2.
|
Cancer Immunol Immunother
|
1998
|
0.86
|
|
14
|
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer.
|
Br J Cancer
|
2005
|
0.86
|
|
15
|
FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
|
Ann Oncol
|
2006
|
0.85
|
|
16
|
Gemcitabine and vinorelbine in pretreated advanced breast cancer: a pilot study.
|
Ann Oncol
|
2000
|
0.84
|
|
17
|
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized study.
|
Melanoma Res
|
2003
|
0.84
|
|
18
|
Opioid plasma concentration during switching from morphine to methadone: preliminary data.
|
Support Care Cancer
|
2003
|
0.82
|
|
19
|
Mitomycin "C" and vinorelbine as second line chemotherapy for metastatic breast carcinoma.
|
Tumori
|
1994
|
0.81
|
|
20
|
Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
|
Br J Cancer
|
1997
|
0.81
|
|
21
|
Thyroid cancer: different outcomes to chemotherapy according to tumour histology.
|
Eur J Cancer
|
1995
|
0.80
|
|
22
|
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer.
|
Eur J Cancer
|
2011
|
0.80
|
|
23
|
Primary extranodal non-Hodgkin lymphomas of the uterus and the breast: report of three cases.
|
Eur J Surg Oncol
|
1995
|
0.79
|
|
24
|
A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
|
Eur J Cancer
|
1993
|
0.79
|
|
25
|
The in vitro effect of the antineoplastic agent bryostatin 4 on human hematopoietic progenitor cells.
|
Haematologica
|
1989
|
0.79
|
|
26
|
Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study.
|
Br J Cancer
|
1990
|
0.79
|
|
27
|
5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group.
|
Ann Oncol
|
2000
|
0.79
|
|
28
|
Cisplatinum in combination with 5-fluorouracil and citrovorum factor in the treatment of advanced colorectal carcinoma.
|
Cancer Invest
|
1992
|
0.78
|
|
29
|
Cis-diamminodichloroplatinum plus a 5-day continuous infusion of 5-fluorouracil in the treatment of locally recurrent and metastatic head and neck cancer patients.
|
J Cancer Res Clin Oncol
|
1989
|
0.78
|
|
30
|
Cetuximab: clinical results in colorectal cancer.
|
Ann Oncol
|
2007
|
0.78
|
|
31
|
Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial.
|
Lung Cancer
|
2001
|
0.78
|
|
32
|
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial.
|
Oncology
|
2008
|
0.78
|
|
33
|
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
|
Ann Oncol
|
2005
|
0.78
|
|
34
|
Escalating doses of mitoxantrone with granulocyte colony-stimulating factor (G-CSF) rescue plus 5-fluorouracil and high-dose levofolinic acid in metastatic breast cancer.
|
Eur J Cancer
|
1994
|
0.78
|
|
35
|
Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer.
|
Ann Oncol
|
2005
|
0.78
|
|
36
|
Results of the combination of cisplatin, adriamycin and cyclophosphamide in the treatment of ovarian carcinoma.
|
Eur J Gynaecol Oncol
|
1993
|
0.77
|
|
37
|
Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinoma.
|
Anticancer Res
|
1998
|
0.77
|
|
38
|
5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group.
|
Cancer
|
1999
|
0.77
|
|
39
|
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.
|
Br J Cancer
|
1998
|
0.77
|
|
40
|
Vinblastine and interferon-alpha-2a regimen in the treatment of metastatic renal cell carcinoma.
|
Tumori
|
1990
|
0.76
|
|
41
|
Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: a multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603).
|
Lung Cancer
|
2010
|
0.76
|
|
42
|
A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinoma.
|
Clin Ter
|
1999
|
0.76
|
|
43
|
Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: phase II study of the Southern Italy Oncology Group (GOIM).
|
Am J Clin Oncol
|
1999
|
0.76
|
|
44
|
Soluble interleukin-2 receptor in vitro production by mononuclear cells from Hodgkin patients.
|
Boll Ist Sieroter Milan
|
1990
|
0.76
|
|
45
|
Single agent paclitaxel in the treatment of unresectable and/or metastatic pancreatic adenocarcinoma.
|
Eur J Cancer
|
1996
|
0.75
|
|
46
|
Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM).
|
Br J Cancer
|
1995
|
0.75
|
|
47
|
Usefulness of oral medroxyprogesterone acetate in the management of cancer-related cachexia-anorexia syndrome.
|
Oncol Rep
|
1996
|
0.75
|
|
48
|
Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinoma.
|
Int J Oncol
|
1996
|
0.75
|
|
49
|
Cyclophosphamide plus epidoxorubicin and 5-fluorouracil with folinic acid as a novel treatment in metastatic breast cancer: preliminary results of a phase II study.
|
J Chemother
|
1991
|
0.75
|
|
50
|
A phase I-II study of cyclophosphamide, epidoxorubicin, levofolinic acid/5-fluorouracil and recombinant human granulocyte colony stimulating factor in metastatic breast carcinoma.
|
Acta Oncol
|
1994
|
0.75
|
|
51
|
Recombinant alpha 2 interferon in the treatment of chronic myeloproliferative disorders.
|
J Chemother
|
1989
|
0.75
|
|
52
|
Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer.
|
Int J Oncol
|
1996
|
0.75
|
|
53
|
Effect of human granulocyte colony stimulating factor (G-CSF) and reduced glutathione (GSH) on drug-induced leukopenia in golden Syrian hamsters.
|
Pharmacol Res
|
1991
|
0.75
|
|
54
|
Cisplatin plus vp16 as salvage treatment for advanced breast-carcinoma resistant or recurrent after 1st line chemotherapy for metastatic disease.
|
Oncol Rep
|
1995
|
0.75
|
|
55
|
Thymopentin (TP 5) in the management of patients with uremia.
|
J Chemother
|
1989
|
0.75
|
|
56
|
Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium.
|
Oncol Rep
|
2005
|
0.75
|
|
57
|
Epidoxorubicin and double biochemical 5-fluorouracil modulation with folinic acid and human lymphoblastoid interferon in advanced gastric carcinoma: a multicentric phase II study of the Southern Italy Oncology Group (GOIM).
|
Oncology
|
1996
|
0.75
|
|
58
|
Scientific activity and needs among medical oncology units in sicily: a survey of the italian association of medical oncology.
|
J Chemother
|
2010
|
0.75
|
|
59
|
Combination chemotherapy with mitomycin C, vindesine and melphalan for refractory metastatic breast cancer.
|
J Cancer Res Clin Oncol
|
1991
|
0.75
|
|
60
|
Combination chemotherapy with cyclophosphamide, doxorubicin and vincristine in the treatment of stage III-IV small-cell lung cancer.
|
J Chemother
|
1989
|
0.75
|
|
61
|
Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer.
|
Am J Clin Oncol
|
1996
|
0.75
|
|
62
|
Acute myocardial effects of mitoxantrone in the rabbit.
|
Cancer Treat Rep
|
1987
|
0.75
|
|
63
|
A phase I-II study on the toxicity and therapeutic efficacy of 5-fluorouracil in combination with leucovorin and cisplatinum in patients with advanced colorectal carcinoma.
|
J Chemother
|
1990
|
0.75
|
|
64
|
Cyclophosphamide plus vincristine and prednisone in the treatment of severe pemphigus vulgaris refractory to conventional therapy.
|
J Chemother
|
1992
|
0.75
|
|
65
|
Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study.
|
Anticancer Res
|
2002
|
0.75
|
|
66
|
An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosis.
|
Eur J Cancer
|
1995
|
0.75
|
|
67
|
Randomized phase II noncomparative trial of oral and intravenous doxifluridine plus levo-leucovorin in untreated patients with advanced colorectal carcinoma.
|
Cancer
|
1996
|
0.75
|
|
68
|
Mental nerve invasion by basal cell carcinoma of the chin: a case report.
|
Anticancer Res
|
1999
|
0.75
|
|
69
|
Alpha interferon in the treatment of hairy cell leukemia.
|
J Chemother
|
1989
|
0.75
|
|
70
|
Combined 5-fluorouracil and recombinant alpha-2a-interferon vs. 5-fluorouracil alone in metastatic colorectal carcinoma: a multicenter randomized study.
|
J Surg Oncol Suppl
|
1991
|
0.75
|
|
71
|
Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer.
|
Cancer Chemother Pharmacol
|
1991
|
0.75
|
|
72
|
Mitomycin C and lonidamine as second-line treatment of advanced colorectal cancer patients.
|
Anticancer Res
|
1996
|
0.75
|
|
73
|
A phase I study of cisplatinum plus 5-fluorouracil in modulation with citrovorum factor in metastatic colorectal carcinoma.
|
J Chemother
|
1991
|
0.75
|
|
74
|
5-Fluorouracil and recombinant alpha interferon-2a in the treatment of advanced colorectal carcinoma: a dose optimization study.
|
J Chemother
|
1990
|
0.75
|
|
75
|
5-fluorouracil plus folinic acid with or without ifosfamide in advanced colorectal cancer: a phase II randomized trial.
|
Tumori
|
2000
|
0.75
|
|
76
|
Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukemias and myelodysplastic syndromes.
|
J Chemother
|
1989
|
0.75
|
|
77
|
Perineural infiltration by cutaneous squamous cell carcinomas of the head and neck.
|
Anticancer Res
|
1995
|
0.75
|
|
78
|
Italian clinical research in non-small-cell lung cancer.
|
Ann Oncol
|
2005
|
0.75
|
|
79
|
Dose intensification of mitoxantrone in combination with levofolinic acid, fluorouracil, cyclophosphamide and granulocyte colony stimulating factor support in advanced untreated breast cancer patients. A multicentric phase II study of the Southern Italy Oncology Group.
|
Anticancer Drugs
|
1997
|
0.75
|